» Articles » PMID: 30397425

Current Role of Palliative Interventions in Advanced Pancreatic Cancer

Overview
Specialty Gastroenterology
Date 2018 Nov 7
PMID 30397425
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic adenocarcinoma is the third leading cause of cancer death in the United States. Unfortunately, at diagnosis, most patients are not candidates for curative resection. Surgical palliation, a procedure performed with the intention of relieving symptoms or improving quality of life, comes to the forefront of management. This article reviews the palliative management of unresectable pancreatic cancer, including obstructive jaundice, duodenal obstruction and pain control with celiac plexus block. Although surgical bypasses for both biliary and duodenal obstructions usually achieve good technical success, they result in considerable perioperative morbidity and mortality, even when performed laparoscopically. The effectiveness of self-expanding metal stents for biliary drainage is excellent with low morbidity. Surgical gastrojejunostomy for duodenal obstruction appears to be best for patients with a life expectancy of greater than 2 mo while endoscopic stenting has been shown to be feasible with good symptom relief in those with a shorter life expectancy. Regardless of the palliative procedure performed, all physicians involved must be adequately trained in end of life management to ensure the best possible care for patients.

Citing Articles

IS THERE A ROLE FOR BILIODIGESTIVE BYPASS SURGERY IN TREATING CHOLESTASIS IN ADVANCED PANCREATIC CANCER?.

Stolzemburg L, Tustumi F, Ribeiro T, Jureidini R, Sorbello M, Maluf-Filho F Arq Bras Cir Dig. 2024; 37:e1823.

PMID: 39292098 PMC: 11407092. DOI: 10.1590/0102-6720202400030e1823.


Palliative Stenting for Gastric Outlet Obstruction Secondary to Pancreatic Adenocarcinoma.

Patel D, Bhullar F, Tagliaferri A, Melki G, Grossman M Cureus. 2024; 16(1):e53186.

PMID: 38425636 PMC: 10901673. DOI: 10.7759/cureus.53186.


Principles of Palliative and Supportive Care in Pancreatic Cancer: A Review.

Mazur R, Trna J Biomedicines. 2023; 11(10).

PMID: 37893064 PMC: 10603964. DOI: 10.3390/biomedicines11102690.


The Malignant Obstruction Caused by Pancreatic Cancer Within the Uncinate Process in the Third Portion of the Duodenum.

Inoue T Cureus. 2023; 15(1):e33436.

PMID: 36751213 PMC: 9897716. DOI: 10.7759/cureus.33436.


Surgical exploration without resection in pancreatic and periampullary tumors: Report from a national database.

Sahlstrom E, Nilsson J, Tingstedt B, Bergenfeldt M, Andersson R, Andersson B Scand J Surg. 2020; 110(3):344-350.

PMID: 32299289 PMC: 8551431. DOI: 10.1177/1457496920913669.


References
1.
OBrien D, Shearer M, Waldron R, Horgan P, Given H . The extent of vitamin K deficiency in patients with cholestatic jaundice: a preliminary communication. J R Soc Med. 1994; 87(6):320-2. PMC: 1294558. DOI: 10.1177/014107689408700607. View

2.
Sangisetty S, Miner T . Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012; 4(4):87-95. PMC: 3351493. DOI: 10.4240/wjgs.v4.i4.87. View

3.
Miner T, Brennan M, Jaques D . A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer. Ann Surg. 2004; 240(4):719-26. PMC: 1356473. DOI: 10.1097/01.sla.0000141707.09312.dd. View

4.
Walter D, van Boeckel P, Groenen M, Weusten B, Witteman B, Tan G . Higher quality of life after metal stent placement compared with plastic stent placement for malignant extrahepatic bile duct obstruction: a randomized controlled trial. Eur J Gastroenterol Hepatol. 2016; 29(2):231-237. DOI: 10.1097/MEG.0000000000000762. View

5.
Gillen S, Schuster T, Zum Buschenfelde C, Friess H, Kleeff J . Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010; 7(4):e1000267. PMC: 2857873. DOI: 10.1371/journal.pmed.1000267. View